ArticleAbdominal radiology (New York)2026
Expanding aorto-iliac calcification quantification in kidney transplant recipients: prognostic implications for survival and renal function.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAorto-iliac calcification (AIC) is increasingly recognized as a prognostic marker in kidney transplantation, yet its relationship with long-term outcomes remains unclear. PURPOSE: To evaluate whether pre-transplant AIC scores independently predict post-transplant mortality and renal function (eGFR trajectory) in kidney transplant recipients.
methodsWe retrospectively analyzed 150 renal transplant recipients ≥ 40 years old who underwent pre-transplant abdominopelvic CT within 3 years of surgery (2005-2018). AIC scores were calculated using a modified Agatston method. Primary outcome was all-cause mortality; secondary outcome was longitudinal eGFR. Cox proportional hazards models assessed the association between AIC and mortality. Linear mixed-effects models and nonparametric tests evaluated the relationship between AIC and eGFR trajectory. Time-dependent ROC curves evaluated model discrimination over time.
resultsHigher AIC scores were independently associated with increased mortality (adjusted HR per 100 units: 1.009, 95% CI: 1.004-1.013, p < 0.001). When modeled by quartiles, patients in the highest AIC quartile had a 10.87-fold higher adjusted mortality risk than those in the lowest (p < 0.001). AIC was not significantly associated with eGFR decline in either multivariable models or sensitivity analyses. Time-dependent AUCs ranged from 0.70 to 0.79 across 2-11 years, demonstrating stable model discrimination.
conclusionAIC is a robust predictor of post-transplant mortality but not of eGFR trajectory. Incorporating AIC quantification into pre-transplant evaluations may improve long-term risk stratification and guide clinical decision-making.
Indexed as
Identifiers
40590968What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.